Literature DB >> 16455168

Intranasal immunization of Balb/c mice against prion protein attenuates orally acquired transmissible spongiform encephalopathy.

Steffen Bade1, Michael Baier, Thurid Boetel, Andreas Frey.   

Abstract

To test whether prion protein (PrP) specific secretory immunoglobulin A (sIgA) can be induced and protect against oral transmission of spongiform encephalopathy (SE) we immunized Balb/c mice either intragastrically or intranasally (i.n.) with a recombinant PrP-fragment (PrP90-231) and cholera toxin (CT) adjuvant. Since PrP90-231 was rapidly digested in intestinal lavage, aprotinin was added to some vaccine formulations. While an anti-CT response was elicited via both routes, solely i.n. immunization without aprotinin induced PrP-specific sIgA. They recognize predominantly PrP-oligomers as the antigen was aggregated in the vaccine formulations. Challenge experiments showed that the immune response induced by our protocol could not prevent disease, but increases the median survival of the animals. We conclude that PrP-specific sIgA reduce the infectivity of the inoculum and that complete protection against transmission of SE should be achievable by optimized immunization regimens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455168     DOI: 10.1016/j.vaccine.2005.12.051

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Immunotherapy in prion disease.

Authors:  Yvonne Roettger; Yansheng Du; Michael Bacher; Inga Zerr; Richard Dodel; Jan-Philipp Bach
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

2.  High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice.

Authors:  F Goñi; F Prelli; F Schreiber; H Scholtzova; E Chung; R Kascsak; D R Brown; E M Sigurdsson; J A Chabalgoity; T Wisniewski
Journal:  Neuroscience       Date:  2008-03-06       Impact factor: 3.590

3.  Toxic effects of intracerebral PrP antibody administration during the course of BSE infection in mice.

Authors:  Maxime Lefebvre-Roque; Elisabeth Kremmer; Sabine Gilch; Wen-Quan Zou; Cécile Féraudet; Chantal Mourton Gilles; Nicole Salès; Jacques Grassi; Pierluigi Gambetti; Thierry Baron; Hermann Schätzl; Corinne Ida Lasmézas
Journal:  Prion       Date:  2007-07-15       Impact factor: 3.931

Review 4.  The immunobiology of prion diseases.

Authors:  Adriano Aguzzi; Mario Nuvolone; Caihong Zhu
Journal:  Nat Rev Immunol       Date:  2013-11-05       Impact factor: 53.106

Review 5.  Prion protein-specific antibodies-development, modes of action and therapeutics application.

Authors:  Tihana Lenac Rovis; Giuseppe Legname
Journal:  Viruses       Date:  2014-10-01       Impact factor: 5.048

6.  Dendritic cell-mediated-immunization with xenogenic PrP and adenoviral vectors breaks tolerance and prolongs mice survival against experimental scrapie.

Authors:  Martine Bruley Rosset; Antoine Sacquin; Sylvie Lecollinet; Thomas Chaigneau; Micheline Adam; François Crespeau; Marc Eloit
Journal:  PLoS One       Date:  2009-03-19       Impact factor: 3.240

7.  Induction of PrPSc-specific systemic and mucosal immune responses in white-tailed deer with an oral vaccine for chronic wasting disease.

Authors:  Ryan Taschuk; Erin Scruten; Murray Woodbury; Neil Cashman; Andrew Potter; Philip Griebel; Suresh K Tikoo; Scott Napper
Journal:  Prion       Date:  2017-09-03       Impact factor: 3.931

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.